The Opioid Crisis: "Prescribing laws, harm reduction, and the role of naloxone"
It is important for healthcare providers to have a good understanding of how to properly prescribe controlled substances for acute and chronic pain. The state of TN requires education related to this topic for licensure. This course is being provided to help improve knowledge of prescribing laws and harm reduction and to facilitate the best outcomes for patients and prevent misuse. This course will meet the mandatory 2 hours of continuing education related to prescribing controlled substances.
MDs, Nurse Practitioners, Nurses, Physician Assistants, Certified Nurse Midwives, Dentists, Pharmacists
- Describe the current opioid epidemic and its effect on Tennesseans.
- Apply the provisions of Public Chapter 1039 to controlled substance prescribing and dispensing in daily practice.
- Summarize and demonstrate essential patient overdose education elements for community and health care settings.
- Evaluate a model for overdose education and naloxone distribution that is most applicable to various community and practice settings.
|The Opioid Crisis: "Prescribing Laws, Harm Reduction, and the Role of Naloxone"|
|Moderator: Jennifer Tourville, DNP||Speakers|
|Welcome/Introductions||Sarah Rhoads PhD, DNP|
|The Opioid Crisis: "Prescribing Laws, Harm Reduction, and the Role of Naloxone"||Brian Winbigler, PharmD, MBA|
|Q&A and Evaluation|
Conflicts of Interest: A Conflict of Interest occurs when an individual has an opportunity to affect educational content about health-care products or services of a commercial interest with which she/he has a financial relationship.
The planners and presenters of this CME/NCPD activity have disclosed no relevant financial relationships with any commercial interests pertaining to this activity.
Commercial Support: No
Noncommercial Sponsor Support: No
Off-label Product Use: This CME/NCPD activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCPD Credit Designation: The University of Tennessee Health Science Center, Memphis designates this enduring activity for a maximum of 2.25 hours NCPD credits. To receive full contact credits, you must be view at least 80% of the program, and complete and submit the evaluation at the conclusion of the presentation.
Continuing Education for Non-Physicians: Certificates of Participation to non-physicians and non-nurses will be awarded for participation in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded 1 CEU.
Successful Completion of this CME/Nursing Professional Development Activity:
In order to receive full contact-hour credit for this CME/NCPD activity, you must:
- View at least 80% of the program, and
- Complete and submit the Evaluation through the link provided at the conclusion of the program.
This activity has been planned and implemented in accordance with the accreditation requirements & policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the UTCOM and the University of Tennessee Health Science Center, Memphis College of Nursing. The UTCOM is accredited by the ACCME to provide continuing medical education for physicians
The University of TN Health Science Center College of Nursing, Memphis is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 2.25 AMA PRA Category 1 Credit™
- 2.25 ANCC
- 2.25 Attendance
- 2.25 Pharmacotherapeutic